Aventis Files Another Patent Suit Over Allegra

Law360, New York (January 27, 2009, 12:00 AM EST) -- Aventis Pharmaceuticals Inc. has taken another generics maker to court over a proposed generic version of the allergy drug Allegra.

In a suit filed Friday in the U.S. District Court for the District of New Jersey, Aventis claims that India-based Sun Pharmaceuticals Industries Inc. has filed an abbreviated new drug application with the U.S. Food and Drug Administration for a generic version of Allegra, which Aventis says would infringe eight of its patents.

Sun's ANDA claims that its generic version would not infringe Aventis' patents, and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.